Charles Schwab Investment Management Inc. boosted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 0.6% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,759,135 shares of the company's stock after purchasing an additional 27,124 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.59% of Colgate-Palmolive worth $445,931,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in CL. Westend Capital Management LLC increased its holdings in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 140 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in shares of Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after buying an additional 287 shares during the last quarter. Vermillion Wealth Management Inc. purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at $31,000. Accredited Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $34,000. Finally, Bernard Wealth Management Corp. bought a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $36,000. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Performance
CL traded down $0.00 on Friday, reaching $84.71. The company had a trading volume of 4,133,894 shares, compared to its average volume of 4,850,591. The stock has a 50-day moving average price of $88.76 and a 200-day moving average price of $90.15. Colgate-Palmolive Company has a 1 year low of $82.40 and a 1 year high of $109.30. The company has a quick ratio of 0.28, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The stock has a market capitalization of $68.46 billion, a PE ratio of 23.79, a P/E/G ratio of 4.41 and a beta of 0.35.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.91 EPS. As a group, research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive's dividend payout ratio is currently 58.43%.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on CL shares. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Barclays increased their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Citigroup dropped their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a report on Monday, August 4th. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Wells Fargo & Company decreased their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research report on Monday, August 4th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $98.92.
View Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.